26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

SCD care has improved in recent years especially with hydroxyurea, still a lot needs to be done for early diagnosis and newborn screening in developing countries. Globally we are becoming more aware of the issues pertaining to sickle cell, now, where is the funding to do something about it? There is slow but steady progress. Clearly the problem being addressed is complex and is hard to tackle. I attended the 3rd Global Congress Meeting in India and was impressed with the increasing awareness and discovering a number of dedicated individuals trying to make a difference.

Produktbeschreibung
SCD care has improved in recent years especially with hydroxyurea, still a lot needs to be done for early diagnosis and newborn screening in developing countries. Globally we are becoming more aware of the issues pertaining to sickle cell, now, where is the funding to do something about it? There is slow but steady progress. Clearly the problem being addressed is complex and is hard to tackle. I attended the 3rd Global Congress Meeting in India and was impressed with the increasing awareness and discovering a number of dedicated individuals trying to make a difference.
Autorenporträt
MOHAMMAD NADEEM KHAN est professeur adjoint (contractuel) de l'école d'études en biotechnologie, à l'Université Bastar de Jagdalpur (C.G) et rédacteur associé à MAT ,MEDWIN, Academic Inn Publications .